U-AQP2 excretion rate was decreased in non-ADPKD patients compared to healthy controls during Period 1 (0.4 ng/min vs. 0.7 ng/min, p = 0.039). This evidence concerns the gene AQP2 and autosomal dominant polycystic kidney disease.